Evome Medical Technologies, Inc. Direct Operating Costs
Evome Medical Technologies, Inc. reported Direct Operating Costs of CAD 1.25 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DirectOperatingCosts · last filed 2024-04-16
- Evome Medical Technologies, Inc. direct operating costs for the quarter ending 2023-12-31 was 268.84K CAD, a 13.25% decline year-over-year.
- Evome Medical Technologies, Inc. direct operating costs for the quarter ending 2023-09-30 was 322.64K CAD, a 10.29% increase year-over-year.
- Evome Medical Technologies, Inc. direct operating costs for the quarter ending 2023-06-30 was 325.95K CAD, a 59.38% increase year-over-year.
- Evome Medical Technologies, Inc. direct operating costs for the quarter ending 2023-03-31 was 335.52K CAD, a 13.73% increase year-over-year.
- Evome Medical Technologies, Inc. direct operating costs for fiscal 2023 was 1.25M CAD.
- Evome Medical Technologies, Inc. direct operating costs for fiscal 2022 was 558.39K CAD.
- Evome Medical Technologies, Inc. direct operating costs for fiscal 2021 was 0.00 CAD.
| Period end | Direct Operating Costs 3 month | Direct Operating Costs 6 month | Direct Operating Costs 9 month | Direct Operating Costs 10 month | Direct Operating Costs 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | 268.84K CAD derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 591.48K CAD derived: sum of 2 quarters · filed 2024-04-16 | 917.42K CAD derived: sum of 3 quarters · filed 2024-04-16 | 1.25M CAD 10-K · filed 2024-04-16 | |
| 2023-09-30 | 322.64K CAD 10-Q · filed 2023-11-14 | 648.59K CAD derived: sum of 2 quarters · filed 2023-11-14 | 984.11K CAD 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | 325.95K CAD 10-Q · filed 2023-08-14 | 661.47K CAD 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 335.52K CAD 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | 933.95K CAD 10-K · filed 2024-04-16 | ||||
| 2022-11-30 | 309.90K CAD 10-Q · filed 2023-01-17 | 863.40K CAD 10-Q · filed 2023-01-17 | |||
| 2022-09-30 | 292.53K CAD 10-Q · filed 2023-11-14 | 792.05K CAD 10-Q · filed 2023-11-14 | |||
| 2022-08-31 | 297.14K CAD 10-Q · filed 2022-10-17 | 553.50K CAD 10-Q · filed 2022-10-17 | |||
| 2022-06-30 | 204.51K CAD 10-Q · filed 2023-08-14 | 499.52K CAD 10-Q · filed 2023-08-14 | |||
| 2022-05-31 | 256.36K CAD 10-Q · filed 2022-07-15 | ||||
| 2022-03-31 | 295.01K CAD 10-Q · filed 2023-05-15 | ||||
| 2022-02-28 | 318.65K CAD derived: 10-KT 12 month − 10-Q 9 month · filed 2023-04-03 | 558.39K CAD derived: sum of 2 quarters · filed 2023-04-03 | 558.39K CAD derived: sum of 3 quarters · filed 2023-04-03 | 558.39K CAD 10-KT · filed 2023-04-03 | |
| 2021-12-31 | 361.56K CAD 10-KT · filed 2023-04-03 | ||||
| 2021-11-30 | 239.74K CAD 10-Q · filed 2023-01-17 | 239.74K CAD derived: sum of 2 quarters · filed 2023-01-17 | 239.74K CAD 10-Q · filed 2023-01-17 | ||
| 2021-08-31 | 0.00 CAD 10-Q · filed 2022-10-17 | 0.00 CAD 10-Q · filed 2022-10-17 | |||
| 2021-05-31 | 0.00 CAD 10-Q · filed 2022-07-15 | ||||
| 2021-02-28 | 0.00 CAD 10-K · filed 2022-05-31 |